Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/51080
Título: | Should the Presence of Metastatic Para-Aortic Lymph Nodes in Locally Advanced Cervical Cancer Lead to More Aggressive Treatment Strategies? | Autores/as: | Benito, Virginia Carballo Rastrilla, Sonia Silva, Patricia Esparza, Miriam Arencibia, Octavio Federico, Mario Andújar, Miguel Mori, Marta Medina Ramos, Norberto Fidel Lubrano, Amina |
Clasificación UNESCO: | 32 Ciencias médicas 320101 Oncología 320108 Ginecología |
Palabras clave: | Chemoradiotherapy Extraperitoneal para-aortic lymphadenectomy Locally advanced cervical cancer Metastatic para-aortic nodes Survival rate |
Fecha de publicación: | 2017 | Publicación seriada: | Journal of Minimally Invasive Gynecology | Resumen: | Study Objective To evaluate risk factors in patients with locally advanced cervical cancer (LACC) undergoing pretherapeutic laparoscopic para-aortic lymphadenectomy (LPL) as well as the progression-free and overall survival rates specifically in the subgroup of patients with metastatic para-aortic lymph nodes (PLNs). Design Retrospective study conducted on demographic data, pathologic and surgical findings, complications, and disease status recorded for LACC patients undergoing LPL during the period 2009 to 2015. Setting Department of Gynecologic Oncology of the Complejo Hospitalario Universitario Insular-Materno Infantil, Canary Islands, Spain (Canadian Task Force Classification II-3). Patients Women with LACC undergoing pretherapeutic LPL. All patients were treated with definitive chemoradiotherapy after surgery, and those with metastatic PLN received extended lumboaortic radiation therapy. Interventions Survival analysis was performed with the Kaplan-Meier method. Statistical significance was considered for p <.05. Measurements and Main Results The study included 139 patients. The median age was 48 years (range, 28–73). The most frequent histologic type was squamous cell carcinoma (77%), and the most frequent 2009 FIGO stage was IIB (48.2%). LPL identified metastatic PLN in 18.7% of patients (n = 26). The mean overall survival for the whole population, after 23 months of follow-up, was 68.2 months (95% CI, 63–73.4). For patients without para-aortic metastases, the mean survival time was 76.9 months (95% CI, 70.3–80.4), whereas for patients with positive PLNs the median survival time was 21 months (95% CI, 6.1–35.9; p <.0001). A logistic regression analysis revealed that the presence of metastatic PLNs and tumor size (>5 cm) were both independent risk factors for poor survival (OR, 117.5; 95% CI, 11.6–990.2; p <.0001, and OR, 21.5; 95% CI, 2–230.3; p = .01, respectively). Conclusion LACC patients with metastatic PLNs had a poor prognosis and low survival rate. We postulate that this finding could be accounted for by the presence of hidden systemic disease and high recurrence rate after therapy. Efforts should be made to improve available therapeutic strategies for this particular subgroup of patients. | URI: | http://hdl.handle.net/10553/51080 | ISSN: | 1553-4650 | DOI: | 10.1016/j.jmig.2017.01.016 | Fuente: | Journal of Minimally Invasive Gynecology[ISSN 1553-4650],v. 24(4), p. 609-616 (Mayo-junio 2017) |
Colección: | Artículos |
Citas SCOPUSTM
19
actualizado el 01-sep-2024
Citas de WEB OF SCIENCETM
Citations
18
actualizado el 01-sep-2024
Visitas
23
actualizado el 20-ene-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.